BenevolentAI

// about BenevolentAI

BenevolentAI uses biomedical knowledge graphs and machine learning to identify novel drug targets and predict how molecules will interact with biological systems. It focuses on diseases with high unmet medical need and has active collaborations with AstraZeneca for atopic dermatitis and heart failure.